SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
296.80
Ask:
297.40
Spread: 0.60 (0.202%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Statement Re: Press Comment

20 Nov 2008 15:32

RNS Number : 6088I
Marwyn Materials Limited
20 November 2008
 



Marwyn Materials Limited ("Marwyn Materials")

STATEMENT REGARDING 

Ennstone PLC ("Ennstone")

Further to recent speculation, Marwyn Materials confirms that it has made an approach to the board of Ennstone in order to explore a possible transaction which may or may not be an offer. 

Shareholders should be aware that there is no certainty that any transaction will occur and a further announcement will be made as and when appropriate.

For the purposes of Rule 2.10 of the City Code on Takeovers and Mergers, Marwyn Materials confirms that it has 136,000,000 ordinary shares of no par value in issue at the close of business on 19 November 2008. The ISIN reference for these securities is JE00B2419D89.

Enquiries:

For further information, please contact:

Marwyn Materials Limited

Peter Tom

020 7389 6800

Simon Vivian

020 7389 6800

Collins Stewart Europe Limited (Nominated Adviser)

Stewart Wallace, Lorraine Delannoy

020 7523 8350

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Marwyn Materials or of Ennstone all dealings in any relevant securities of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3:30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Marwyn Materials or of Ennstone, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Marwyn Materials or of Ennstone by Marwyn Materials or Ennstone, or by any of their respective "associates", must be disclosed by no later than 12:00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SPCFGMZMKGGGRZM
Date   Source Headline
7th Jul 20217:00 amRNSBlock listing Update
1st Jul 20216:16 pmRNSTotal Voting Rights
1st Jun 20213:49 pmRNSStandard form for notification of major holdings
1st Jun 20217:00 amRNSAcquisition
28th May 202110:02 amRNSTotal Voting Rights
7th May 20219:28 amRNSStandard form for notification of major holdings
23rd Apr 20211:46 pmRNSDirectors’ and PDMRs’ Dealings
23rd Apr 20211:37 pmRNSPDMR Dealings
20th Apr 20212:36 pmRNSResult of AGM
20th Apr 20217:00 amRNSAGM Trading Update
1st Apr 202111:04 amRNSGrant of SAYE Options and PDMR Dealings
1st Apr 20217:00 amRNSBoard Update
23rd Mar 202111:13 amRNSDirector Dealings
23rd Mar 202111:09 amRNS2020 Annual Report and Notice of AGM
10th Mar 20217:01 amRNSDirectorate Change
10th Mar 20217:00 amRNSAnnual Results 2020
26th Feb 20219:15 amRNSTotal Voting Rights
22nd Jan 20211:55 pmRNSDirector/PDMR Shareholding
22nd Jan 20218:46 amRNSAdditional Block Listing of Ordinary Shares
13th Jan 20217:00 amRNSAppointment of Corporate Broker
7th Jan 20212:45 pmRNSBlock listing Interim Review
23rd Dec 20207:00 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSTrading Update
3rd Dec 20207:00 amRNSUpdate on CMA's Review of Completed Acquisition
2nd Dec 20203:55 pmRNSHolding(s) in Company
1st Dec 20204:50 pmRNSHolding(s) in Company
1st Dec 20207:10 amRNSUpdate on CMA's Review of Completed Acquisition
30th Nov 20201:31 pmRNSTotal Voting Rights
24th Nov 20204:55 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSDirectorate Change
18th Nov 20207:00 amRNSTrading Update
9th Nov 20207:00 amRNSAcquisition update
30th Oct 20207:00 amRNSTotal Voting Rights
6th Oct 20207:00 amRNSDirectorate Change
30th Sep 20207:00 amRNSTotal Voting Rights
17th Sep 20207:00 amRNSTrading Update
10th Sep 20207:13 amRNSCMA's Review of Completed Acquisition
7th Sep 202012:50 pmRNSGrant of SAYE Options and PDMR Dealings
27th Aug 20202:53 pmRNSDirectors' and PDMRs' Dealings
26th Aug 20207:14 amRNSCMA's Review of Proposed Acquisition
19th Aug 20205:30 pmRNSHolding(s) in Company
19th Aug 20205:30 pmRNSHolding(s) in Company
13th Aug 20204:09 pmRNSDirector and PDMR Dealings
3rd Aug 20207:00 amRNSCompletion of acquisition
31st Jul 20207:00 amRNSTotal Voting Rights
29th Jul 20207:00 amRNSHalf-year Report
8th Jul 20207:00 amRNSBlock listing Interim Review
6th Jul 202010:30 amRNSHolding(s) in Company
6th Jul 202010:30 amRNSHolding(s) in Company
19th Jun 20203:41 pmRNSDirector and PDMR Dealings & Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.